Uniphos Enter.

Why is Uniphos Enterprises Ltd falling/rising?

As of 21-Jul, Uniphos Enterprises Ltd's stock is rising by 0.79% after two days of decline, indicating a potential trend reversal. However, it has a year-to-date decline of 29.99% and is trading below its moving averages, suggesting a longer-term bearish trend.

As of 21-Jul, Uniphos Enterprises Ltd's stock price is currently rising, with a change of 0.8 (0.79%) upwards. This increase comes after two consecutive days of decline, indicating a potential trend reversal. Additionally, the stock has outperformed its sector by 1.56% today, which may contribute to the positive momentum. <BR><BR>However, it is important to note that despite this recent rise, the stock has been underperforming over longer periods, with a year-to-date decline of 29.99% and a one-year decline of 35.33%. The stock is currently trading below its moving averages across various time frames, suggesting a longer-term bearish trend. Furthermore, there has been a significant drop in investor participation, with delivery volume falling by 78.74% against the five-day average, which could indicate a lack of confidence among investors.<BR><BR>In summary, while the stock is experiencing a short-term rise today, the overall performance metrics suggest a challenging environment for Uniphos Enterprises Ltd in the longer term.

Which are the latest news on Uniphos Enter.?

How big is Uniphos Enter.?

As of 10th June, Uniphos Enterprises Ltd has a market capitalization of 725.00 Cr, with recent net sales of 32.00 Cr and a net profit of 20.71 Cr.

As of 10th June, Uniphos Enterprises Ltd has a market capitalization of 725.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Uniphos Enterprises Ltd reported Net Sales of 32.00 Cr and a Net Profit of 20.71 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 2,741.65 Cr and Total Assets of 2,841.71 Cr.

Who are in the management team of Uniphos Enter.?

The management team of Uniphos Enterprises includes R D Shroff (Managing Director), S R Shroff (Vice Chairperson), J R Shroff (Non-Executive Director), A C Ashar (Chairman), Pradeep Goyal and Swati S Mayekar (Non-Executive Independent Directors), and K M Thacker (Company Secretary). They oversee the company's operations and strategic direction.

The management team of Uniphos Enterprises includes the following individuals:<BR><BR>1. R D Shroff - Managing Director<BR>2. S R Shroff - Vice Chairperson<BR>3. J R Shroff - Non-Executive & Non-Independent Director<BR>4. A C Ashar - Chairman (Non-Executive)<BR>5. Pradeep Goyal - Non-Executive & Independent Director<BR>6. Swati S Mayekar - Non-Executive & Independent Director<BR>7. K M Thacker - Company Secretary & Compliance Officer<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

Who are the peers of the Uniphos Enter.?

Uniphos Enter.'s peers include Creative Newtech, Kokuyo Camlin, R M Drip & Sprin, Linc, and others. In terms of management risk, growth, and capital structure, Uniphos Enter. shows below average performance compared to its peers.

Peers: The peers of Uniphos Enter. are Creative Newtech, Kokuyo Camlin, R M Drip & Sprin, Linc, Everest Inds., Vision Infra, Vasa Denticity, Kapston Services, Tembo Global, and Namo eWaste.<BR><BR>Quality Snapshot: Excellent management risk is observed at Creative Newtech, R M Drip & Sprin, Linc, Tembo Global, and Namo eWaste, while Average management risk is found at Kokuyo Camlin, Uniphos Enter., Vision Infra, Kapston Services, and the rest. Good growth is seen at Kokuyo Camlin, Linc, Vision Infra, Kapston Services, and Tembo Global, whereas Uniphos Enter. shows below average growth, and the rest have either excellent or average growth. For capital structure, Excellent is noted at Linc and Vasa Denticity, Good at Kokuyo Camlin and Linc, while Uniphos Enter. has below average capital structure, and the rest have varying ratings.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Creative Newtech with N/A, while the peer with the lowest is Kokuyo Camlin at -35.12%. Uniphos Enter.'s 1-year return is -28.79%, which is better than Kokuyo Camlin but worse than Creative Newtech. Additionally, Everest Inds. has a negative six-month return of -33.51%, and Linc, Vision Infra, Vasa Denticity, Kapston Services, Tembo Global, and Namo eWaste have zero returns over the same period.

What does Uniphos Enter. do?

Uniphos Enterprises Ltd is a micro-cap company specializing in the manufacturing of specialty chemicals, including phosphorus compounds and pesticides. As of March 2026, it reported net sales of 26 Cr and a net loss of 1 Cr, with a market cap of INR 725 Cr.

Overview:<BR>Uniphos Enterprises Ltd is a micro-cap company in the miscellaneous industry, primarily engaged in the manufacturing of specialty chemicals, including phosphorus compounds, pesticides, dyes, and mercury salts.<BR><BR>History:<BR>Established in 1969 as United Phosphorus Limited, the company has evolved from producing red phosphorus to becoming a significant manufacturer and exporter of organic and inorganic mercury compounds in India. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Most recent Net Sales: 26 Cr (Quarterly Results - Mar 2026)<BR>- Most recent Net Profit: -1 Cr (Quarterly Results - Mar 2026)<BR>- Market-cap value: INR 725 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 35.00<BR>- Industry P/E: 21<BR>- Dividend Yield: 0.47%<BR>- Debt Equity: -0.01<BR>- Return on Equity: 0.85%<BR>- Price to Book: 0.30<BR><BR>Contact Details:<BR>Address: 11 GIDC, Valsad Dist VAPI Gujarat : 396195 <BR>Tel: 91-0260-2400717 <BR>Email: thackerkm@uniphos.com <BR>Website: http://www.uelonline.com

Should I buy, sell or hold Uniphos Enterprises Ltd?

Are Uniphos Enterprises Ltd latest results good or bad?

Uniphos Enterprises Ltd's latest Q4 FY26 results are unfavorable, showing a net loss of ₹0.70 crores and a significant 64.14% decline in revenue year-over-year. Despite a slight improvement in losses compared to last year, the company's negative margins and low return on equity indicate ongoing operational challenges.

Uniphos Enterprises Ltd's latest results for Q4 FY26 indicate a challenging financial situation. The company reported a net loss of ₹0.70 crores, which, while an improvement from a loss of ₹1.58 crores in the same quarter last year, still reflects ongoing operational weaknesses. Revenue for the quarter was ₹26.14 crores, marking a significant decline of 64.14% year-over-year from ₹72.90 crores in Q4 FY25.<BR><BR>The company's profitability metrics remain concerning, with a negative PAT margin of -2.68%, which is worse than the previous year's -2.17%. Additionally, the return on equity (ROE) is extremely low at 0.73%, indicating poor capital efficiency. The overall financial performance has been erratic, with extreme revenue volatility and persistent losses raising serious questions about the company's business model and viability.<BR><BR>In summary, while there is a slight narrowing of losses compared to the previous year, the overall financial results are poor, characterized by significant revenue decline, negative margins, and weak operational performance. This paints a picture of a company facing substantial challenges, making the latest results largely unfavorable.

When is the next results date for Uniphos Enterprises Ltd?

The next results date for Uniphos Enterprises Ltd is 27 May 2026.

The next results date for Uniphos Enterprises Ltd is scheduled for 27 May 2026.

Is Uniphos Enter. technically bullish or bearish?

As of December 4, 2025, the technical trend has shifted to a moderately strong bearish stance, driven by bearish MACD, Bollinger Bands, and moving averages, despite a mildly bullish OBV signal on the monthly chart.

As of 4 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength. Key indicators driving this include a bearish MACD on the weekly timeframe, bearish signals from Bollinger Bands on both weekly and monthly charts, and bearish moving averages on the daily chart. The KST is also bearish across both timeframes. Although the OBV shows a mildly bullish signal on the monthly, it does not outweigh the overall bearish indicators.

How has been the historical performance of Uniphos Enter.?

Uniphos Enter. has shown significant sales growth, with net sales rising from 1.47 Cr in March 2023 to 111.51 Cr in March 2025. However, it faces profitability challenges, as operating profit declined and cash flow from operations remained negative.

Answer:<BR>The historical performance of Uniphos Enter. shows significant fluctuations in its financial metrics over the years, particularly from March 2019 to March 2025.<BR><BR>Breakdown:<BR>Uniphos Enter. experienced a dramatic increase in net sales from 1.47 Cr in March 2023 to 111.51 Cr in March 2025, reflecting a substantial growth trajectory. However, the total expenditure also rose sharply, leading to an operating profit (PBDIT) of 2.29 Cr in March 2025, down from 39.78 Cr in March 2024. This decline in operating profit is accompanied by a negative operating profit margin of -3.43% in March 2025, indicating challenges in managing costs relative to revenue. Profit before tax decreased to 0.23 Cr in March 2025 from 38.94 Cr in March 2024, while profit after tax also fell to 0.28 Cr from 38.61 Cr in the previous year. The company's reserves increased to 2,727.74 Cr in March 2025, up from 2,061.54 Cr in March 2024, yet the book value per share adjusted to 373.37 in March 2025 from 277.58 in March 2024. Cash flow from operating activities remained negative at -2.00 Cr in March 2025, although cash flow from investing activities improved to 52.00 Cr. Overall, while Uniphos Enter. has shown remarkable sales growth, it faces challenges in profitability and cash flow management.

Who are the top shareholders of the Uniphos Enter.?

The top shareholders of Uniphos Enterprises include Nerka Chemicals Pvt Ltd with 73.29%, 15 Foreign Institutional Investors holding 15.72%, and Ares Diversified as the largest public shareholder at 4.56%. Individual investors own 8.91%, with no pledged promoter holdings reported.

The top shareholders of Uniphos Enterprises include the promoters, with Nerka Chemicals Pvt Ltd holding the largest share at 73.29%. Additionally, 15 Foreign Institutional Investors (FIIs) collectively hold 15.72% of the shares. The highest public shareholder is Ares Diversified, which owns 4.56%. Individual investors account for 8.91% of the shareholding. There are no pledged promoter holdings reported.

Has Uniphos Enter. declared dividend?

Uniphos Enterprises Ltd has declared a 285% dividend, amounting to ₹5.7 per share, with an ex-date of September 6, 2024. The company has shown strong total returns across various periods, particularly a 225.14% total return over the past five years.

Uniphos Enterprises Ltd has declared a 285% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 285%<BR>- Amount per share: 5.7<BR>- Ex-date: 06 Sep 2024<BR><BR>Dividend Yield: 3.56%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was 0.95%, with no dividend return, resulting in a total return of 0.95%.<BR><BR>For the 1-year period, the price return was 0.25%, with a dividend return of 3.45%, leading to a total return of 3.7%.<BR><BR>Over the 2-year period, the price return was 4.95%, the dividend return was 7.66%, culminating in a total return of 12.61%.<BR><BR>In the 3-year period, the price return was 28.23%, with a dividend return of 14.76%, resulting in a total return of 42.99%.<BR><BR>During the 4-year period, the price return was 32.78%, the dividend return was 16.29%, leading to a total return of 49.07%.<BR><BR>Finally, in the 5-year period, the price return was 189.62%, with a dividend return of 35.52%, resulting in a total return of 225.14%.<BR><BR>Overall, Uniphos Enterprises Ltd has shown a strong commitment to returning value to shareholders through its significant dividend declaration and has demonstrated positive total returns across all periods, particularly over the longer term.